OT
Orchard TherapeuticsDirector, GCP, QA
Director responsible for establishing and executing strategy for GCP, GVP, & GLP compliance oversight. Driving continuous improvement and ensuring compliance with global regulations in London.
OT
Orchard Therapeutics
Currently Hiring
About the company
At Orchard Therapeutics, our vision is to end the devastation caused by genetic and other severe diseases.
We aim to do this by discovering, developing and commercializing new treatments that tap into the curative potential of hematopoietic stem cell (HSC) gene therapy.
In this approach, a patient’s own blood stem cells are genetically modified outside of the body and then reinserted, with the goal of correcting the underlying cause of disease in a single treatment.
In 2018, the company acquired GSK’s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy.
Today, Orchard is advancing a pipeline spanning pre-clinical, clinical and commercial stage HSC gene therapies designed to address serious diseases where the burden is immense for patients, families and society and current treatment options are limited or do not exist.
Orchard has its global headquarters in London and U.S.
headquarters in Boston.
For more information, please visit www.orchard-tx.com,
Open jobs
Browse and apply for open jobs at Orchard Therapeutics.
1 jobs found